Karvonen S, Jokinen K, Karvonen P, Hollmén A
Acta Anaesthesiol Scand. 1976;20(2):156-9. doi: 10.1111/j.1399-6576.1976.tb05022.x.
Arterial and venous blood lidocaine concentrations were intermittently measured in 15 bronchoscopy patients in whom local anaesthesia was induced by an inhalation technique. A DeVillbiss ultrasonic nebulizer model 3574 was used. The anaesthetic was 10 ml of 4% lidocaine without adrenaline. Blood concentrations were measured 5 min after commencement of inhalation, on completion of inhalation, and then after 10, 30 and 60 min. Statistically significantly higher concentrations were found in the arterial blood at the first two sampling times (P less than 0.01 and P less than 0.05, respectively). The highest average concentration in both arterial and venous blood eas reached 10 min after completion of anaesthesia. After 30 min, there was no difference between the arterial and venous samples; and after 60 min, the concentration was higher in venous blood. The highest individual concentration was 2.8 mug/ml in arterial blood and 2.1 mug/ml in venous blood, well below that reported to cause systemic toxic symptoms. Thus, the inhalation technique may be considered a safe means of inducing anaesthesia in the respiratory tract.
对15例采用吸入技术进行局部麻醉的支气管镜检查患者,间歇性测量其动脉血和静脉血中的利多卡因浓度。使用的是德维比斯3574型超声雾化器。麻醉剂为10毫升不含肾上腺素的4%利多卡因。在吸入开始后5分钟、吸入结束时,以及随后的10分钟、30分钟和60分钟测量血药浓度。在前两个采样时间点,动脉血中的浓度在统计学上显著更高(分别为P<0.01和P<0.05)。麻醉结束后10分钟,动脉血和静脉血中的平均浓度均达到最高。30分钟后,动脉血和静脉血样本之间没有差异;60分钟后,静脉血中的浓度更高。动脉血中最高的个体浓度为2.8微克/毫升,静脉血中为2.1微克/毫升,远低于报道的引起全身中毒症状的浓度。因此,吸入技术可被认为是一种在呼吸道诱导麻醉的安全方法。